Testing effectiveness (Phase 2)Ended earlyNCT04771000
What this trial is testing
Micro Dose Ambrisentan in Hospitalized Patients With Respiratory Insufficiency Due to COVID-19
Who this might be right for
Covid19Hypoxemia
Noorik Biopharmaceuticals AG 88